

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 4.58143636 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 4.58143636 |
| 3 | protein localization to endosome (GO:0036010) | 4.07203708 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.88665404 |
| 5 | pinocytosis (GO:0006907) | 3.57062376 |
| 6 | barbed-end actin filament capping (GO:0051016) | 3.53945291 |
| 7 | regulation of early endosome to late endosome transport (GO:2000641) | 3.41267113 |
| 8 | glycine metabolic process (GO:0006544) | 3.39847591 |
| 9 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.38305783 |
| 10 | maternal placenta development (GO:0001893) | 3.31609619 |
| 11 | lysine metabolic process (GO:0006553) | 3.29506955 |
| 12 | lysine catabolic process (GO:0006554) | 3.29506955 |
| 13 | stress fiber assembly (GO:0043149) | 3.27478229 |
| 14 | regulation of cholesterol homeostasis (GO:2000188) | 3.25669691 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 3.22740981 |
| 16 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.16499495 |
| 17 | adherens junction assembly (GO:0034333) | 3.14262766 |
| 18 | protein retention in ER lumen (GO:0006621) | 3.12616423 |
| 19 | focal adhesion assembly (GO:0048041) | 3.12300469 |
| 20 | cell-substrate adherens junction assembly (GO:0007045) | 3.12300469 |
| 21 | L-phenylalanine metabolic process (GO:0006558) | 3.11906646 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.11906646 |
| 23 | low-density lipoprotein particle clearance (GO:0034383) | 3.06431918 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 3.02613729 |
| 25 | modulation by symbiont of host cellular process (GO:0044068) | 3.02014141 |
| 26 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.00347321 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 2.93760038 |
| 28 | glyoxylate metabolic process (GO:0046487) | 2.93740589 |
| 29 | kynurenine metabolic process (GO:0070189) | 2.89880720 |
| 30 | 4-hydroxyproline metabolic process (GO:0019471) | 2.89211477 |
| 31 | cell-substrate junction assembly (GO:0007044) | 2.88718432 |
| 32 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.87881438 |
| 33 | negative regulation of cholesterol transport (GO:0032375) | 2.87162881 |
| 34 | negative regulation of sterol transport (GO:0032372) | 2.87162881 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.84576987 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 2.84001716 |
| 37 | pentose-phosphate shunt (GO:0006098) | 2.82902982 |
| 38 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.82891836 |
| 39 | protein carboxylation (GO:0018214) | 2.81393127 |
| 40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.81393127 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 2.80097826 |
| 42 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.80083693 |
| 43 | negative regulation of cell size (GO:0045792) | 2.79760497 |
| 44 | viral transcription (GO:0019083) | 2.78816671 |
| 45 | embryonic process involved in female pregnancy (GO:0060136) | 2.78079018 |
| 46 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.77762028 |
| 47 | serine family amino acid biosynthetic process (GO:0009070) | 2.76237239 |
| 48 | cysteine metabolic process (GO:0006534) | 2.76002327 |
| 49 | L-phenylalanine catabolic process (GO:0006559) | 2.75698459 |
| 50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.75698459 |
| 51 | mannose metabolic process (GO:0006013) | 2.75382317 |
| 52 | 2-oxoglutarate metabolic process (GO:0006103) | 2.73770544 |
| 53 | serine family amino acid metabolic process (GO:0009069) | 2.72428594 |
| 54 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.69346959 |
| 55 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.69333699 |
| 56 | basement membrane organization (GO:0071711) | 2.68938249 |
| 57 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.66187664 |
| 58 | translational termination (GO:0006415) | 2.66010739 |
| 59 | regulation of cholesterol storage (GO:0010885) | 2.64207421 |
| 60 | modulation by virus of host process (GO:0019054) | 2.63289922 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 2.63251770 |
| 62 | regulation of translational fidelity (GO:0006450) | 2.63013937 |
| 63 | folic acid metabolic process (GO:0046655) | 2.61629284 |
| 64 | tetrahydrofolate metabolic process (GO:0046653) | 2.59579986 |
| 65 | regulation of fibrinolysis (GO:0051917) | 2.57586018 |
| 66 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.57192328 |
| 67 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.57192328 |
| 68 | positive regulation of histone deacetylation (GO:0031065) | 2.57051265 |
| 69 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.56975566 |
| 70 | urea cycle (GO:0000050) | 2.56942751 |
| 71 | urea metabolic process (GO:0019627) | 2.56942751 |
| 72 | amino-acid betaine metabolic process (GO:0006577) | 2.55695956 |
| 73 | NADPH regeneration (GO:0006740) | 2.55447864 |
| 74 | activation of Rac GTPase activity (GO:0032863) | 2.55276523 |
| 75 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.54516303 |
| 76 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.54294304 |
| 77 | homocysteine metabolic process (GO:0050667) | 2.53619121 |
| 78 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.53388448 |
| 79 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.52416548 |
| 80 | valine metabolic process (GO:0006573) | 2.52104425 |
| 81 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.51911293 |
| 82 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.51550552 |
| 83 | apoptotic process involved in morphogenesis (GO:0060561) | 2.51295699 |
| 84 | aromatic amino acid family catabolic process (GO:0009074) | 2.50115072 |
| 85 | heterochromatin organization (GO:0070828) | 2.49818044 |
| 86 | complement activation, alternative pathway (GO:0006957) | 2.49296062 |
| 87 | ethanol oxidation (GO:0006069) | 2.48875483 |
| 88 | mitotic chromosome condensation (GO:0007076) | 2.48822799 |
| 89 | proline biosynthetic process (GO:0006561) | 2.47985918 |
| 90 | translational elongation (GO:0006414) | 2.46960721 |
| 91 | regulation of extracellular matrix disassembly (GO:0010715) | 2.46193511 |
| 92 | DNA unwinding involved in DNA replication (GO:0006268) | 2.45628607 |
| 93 | regulation of protein activation cascade (GO:2000257) | 2.44696289 |
| 94 | positive regulation of nuclease activity (GO:0032075) | 2.44336603 |
| 95 | response to peptidoglycan (GO:0032494) | 2.43407860 |
| 96 | activation of MAPKKK activity (GO:0000185) | 2.43086911 |
| 97 | hypotonic response (GO:0006971) | 2.43056822 |
| 98 | epithelial cell-cell adhesion (GO:0090136) | 2.42286736 |
| 99 | apoptotic cell clearance (GO:0043277) | 2.42234373 |
| 100 | cellular response to virus (GO:0098586) | 2.41939059 |
| 101 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.41692972 |
| 102 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.41692972 |
| 103 | modulation by symbiont of host immune response (GO:0052553) | 2.41692972 |
| 104 | positive regulation by symbiont of host defense response (GO:0052509) | 2.41692972 |
| 105 | modulation by symbiont of host defense response (GO:0052031) | 2.41692972 |
| 106 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.41692972 |
| 107 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.41488802 |
| 108 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.40123008 |
| 109 | tricarboxylic acid metabolic process (GO:0072350) | 2.39737334 |
| 110 | nitrogen cycle metabolic process (GO:0071941) | 2.38144301 |
| 111 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.37534683 |
| 112 | response to laminar fluid shear stress (GO:0034616) | 2.37522358 |
| 113 | negative regulation of lipid transport (GO:0032369) | 2.36415140 |
| 114 | negative regulation of necroptotic process (GO:0060546) | 2.36003944 |
| 115 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.35431517 |
| 116 | regulation of complement activation (GO:0030449) | 2.35300328 |
| 117 | hyaluronan catabolic process (GO:0030214) | 2.35197109 |
| 118 | positive regulation of extracellular matrix organization (GO:1903055) | 2.34689308 |
| 119 | glucose catabolic process (GO:0006007) | 2.34546980 |
| 120 | cortical actin cytoskeleton organization (GO:0030866) | 2.34236744 |
| 121 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.33608843 |
| 122 | regulation of defense response to virus by virus (GO:0050690) | 2.32921330 |
| 123 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.32728419 |
| 124 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.32623406 |
| 125 | acetyl-CoA metabolic process (GO:0006084) | 2.32500697 |
| 126 | modulation by virus of host morphology or physiology (GO:0019048) | 2.32374159 |
| 127 | protein maturation by protein folding (GO:0022417) | 2.32014411 |
| 128 | membrane raft organization (GO:0031579) | 2.31815869 |
| 129 | regulation of hippo signaling (GO:0035330) | 2.31511361 |
| 130 | L-serine metabolic process (GO:0006563) | 2.31330798 |
| 131 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.31103290 |
| 132 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.30870252 |
| 133 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.30407380 |
| 134 | positive regulation of receptor recycling (GO:0001921) | 2.30404762 |
| 135 | positive regulation of myotube differentiation (GO:0010831) | 2.29992764 |
| 136 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.29571751 |
| 137 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.29551456 |
| 138 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.28878983 |
| 139 | T cell apoptotic process (GO:0070231) | 2.28622011 |
| 140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.28615940 |
| 141 | regulation of translational termination (GO:0006449) | 2.28225528 |
| 142 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.27695986 |
| 143 | tryptophan catabolic process (GO:0006569) | 2.27139532 |
| 144 | indole-containing compound catabolic process (GO:0042436) | 2.27139532 |
| 145 | indolalkylamine catabolic process (GO:0046218) | 2.27139532 |
| 146 | translational initiation (GO:0006413) | 2.26258970 |
| 147 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.25842100 |
| 148 | negative regulation of viral release from host cell (GO:1902187) | 2.25521897 |
| 149 | response to muramyl dipeptide (GO:0032495) | 2.25080282 |
| 150 | positive regulation of lipid storage (GO:0010884) | 2.23676094 |
| 151 | cellular modified amino acid catabolic process (GO:0042219) | 2.23074198 |
| 152 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.22977937 |
| 153 | regulation of nuclease activity (GO:0032069) | 2.22522195 |
| 154 | negative regulation of fatty acid transport (GO:2000192) | 2.22376415 |
| 155 | folic acid-containing compound metabolic process (GO:0006760) | 2.22363583 |
| 156 | formation of translation preinitiation complex (GO:0001731) | 2.21891014 |
| 157 | ER-nucleus signaling pathway (GO:0006984) | 2.21381600 |
| 158 | regulation of triglyceride catabolic process (GO:0010896) | 2.21117934 |
| 159 | regulation of histone H3-K27 methylation (GO:0061085) | 2.20637833 |
| 160 | regulation of integrin activation (GO:0033623) | 2.20501848 |
| 161 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.20211220 |
| 162 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.18860139 |
| 163 | protein-lipid complex assembly (GO:0065005) | 2.18625880 |
| 164 | tryptophan metabolic process (GO:0006568) | 2.18554475 |
| 165 | RNA stabilization (GO:0043489) | 2.18436802 |
| 166 | mRNA stabilization (GO:0048255) | 2.18436802 |
| 167 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.18284421 |
| 168 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.17507726 |
| 169 | aspartate family amino acid catabolic process (GO:0009068) | 2.17487989 |
| 170 | one-carbon metabolic process (GO:0006730) | 2.17391995 |
| 171 | skin morphogenesis (GO:0043589) | 2.16594750 |
| 172 | protein localization to kinetochore (GO:0034501) | 2.16167327 |
| 173 | cellular protein complex localization (GO:0034629) | 2.15615218 |
| 174 | membrane protein ectodomain proteolysis (GO:0006509) | 2.14691874 |
| 175 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.14589282 |
| 176 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.14125557 |
| 177 | phospholipid homeostasis (GO:0055091) | 2.13899216 |
| 178 | regulation of necroptotic process (GO:0060544) | 2.13112389 |
| 179 | bile acid biosynthetic process (GO:0006699) | 2.13000816 |
| 180 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.12990867 |
| 181 | cellular response to unfolded protein (GO:0034620) | 2.12382308 |
| 182 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.10890177 |
| 183 | adhesion of symbiont to host (GO:0044406) | 2.09020538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.90624380 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.58822850 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.98092764 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.77248038 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.72108741 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.70513828 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.68137157 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.63862989 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.62476239 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.55707577 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.26262204 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.01557375 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.99550602 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97760174 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.97064305 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.95802160 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91607070 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.84086994 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78946478 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.76609612 |
| 21 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.73423647 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65865081 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64206832 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.62364588 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54193489 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52564481 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50860268 |
| 28 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46328273 |
| 29 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.46076834 |
| 30 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.45618187 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.45600692 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.41541807 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39347863 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38792679 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38569799 |
| 36 | ATF3_27146783_Chip-Seq_COLON_Human | 1.38507041 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38414808 |
| 38 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.38325842 |
| 39 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38227991 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.34391257 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.34089797 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33120566 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31366528 |
| 44 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.30828473 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30561482 |
| 46 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30372843 |
| 47 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.29158811 |
| 48 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.28898840 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27979311 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.27733410 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27693165 |
| 52 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26972004 |
| 53 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.26913483 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25788523 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25703404 |
| 56 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25015697 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24516631 |
| 58 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23698870 |
| 59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23462382 |
| 60 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.22796099 |
| 61 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.22027494 |
| 62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20916327 |
| 63 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19293446 |
| 64 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19000436 |
| 65 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18344806 |
| 66 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17369226 |
| 67 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17092103 |
| 68 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16759173 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16652573 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16307732 |
| 71 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15416926 |
| 72 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14995486 |
| 73 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.14668265 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14439111 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14130984 |
| 76 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.13542205 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13363338 |
| 78 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12467150 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12229091 |
| 80 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11872697 |
| 81 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10177837 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08942286 |
| 83 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.08827592 |
| 84 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07794023 |
| 85 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07432632 |
| 86 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.07328930 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.07255155 |
| 88 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06971609 |
| 89 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06652133 |
| 90 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.06476758 |
| 91 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05783026 |
| 92 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05400418 |
| 93 | P68_20966046_ChIP-Seq_HELA_Human | 1.05143346 |
| 94 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05089713 |
| 95 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04697533 |
| 96 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04553401 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04544913 |
| 98 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03554107 |
| 99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03402963 |
| 100 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.02664300 |
| 101 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01093336 |
| 102 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00830272 |
| 103 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00639659 |
| 104 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.98784048 |
| 105 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.97064489 |
| 106 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96871490 |
| 107 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.96767305 |
| 108 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95971371 |
| 109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95426766 |
| 110 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.95400941 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95232634 |
| 112 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95158543 |
| 113 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94772436 |
| 114 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.94398774 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94020374 |
| 116 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93623487 |
| 117 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93319644 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93034834 |
| 119 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92151456 |
| 120 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.91987543 |
| 121 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91249244 |
| 122 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.90548208 |
| 123 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.89705936 |
| 124 | MYB_26560356_Chip-Seq_TH1_Human | 0.89675456 |
| 125 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.89460550 |
| 126 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88795417 |
| 127 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.88659756 |
| 128 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.87433480 |
| 129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87315765 |
| 130 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87143719 |
| 131 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.86554054 |
| 132 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.86268342 |
| 133 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.86082485 |
| 134 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.85445571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.63958680 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.04966850 |
| 3 | MP0005360_urolithiasis | 3.00622687 |
| 4 | MP0009840_abnormal_foam_cell | 2.66534236 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 2.16471518 |
| 6 | MP0005365_abnormal_bile_salt | 2.09713408 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.04589514 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.01057161 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 1.95187814 |
| 10 | MP0003566_abnormal_cell_adhesion | 1.83365949 |
| 11 | MP0005076_abnormal_cell_differentiation | 1.66800302 |
| 12 | MP0003300_gastrointestinal_ulcer | 1.65706302 |
| 13 | MP0008260_abnormal_autophagy | 1.60750272 |
| 14 | MP0003303_peritoneal_inflammation | 1.58996140 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 1.57809559 |
| 16 | MP0004233_abnormal_muscle_weight | 1.57396400 |
| 17 | MP0003252_abnormal_bile_duct | 1.55830232 |
| 18 | MP0004858_abnormal_nervous_system | 1.49733246 |
| 19 | MP0005623_abnormal_meninges_morphology | 1.49269356 |
| 20 | MP0009053_abnormal_anal_canal | 1.48192603 |
| 21 | MP0005023_abnormal_wound_healing | 1.45411951 |
| 22 | MP0005083_abnormal_biliary_tract | 1.45074652 |
| 23 | MP0010329_abnormal_lipoprotein_level | 1.42922413 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.42593432 |
| 25 | MP0004510_myositis | 1.40038773 |
| 26 | MP0000609_abnormal_liver_physiology | 1.37134953 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.36396731 |
| 28 | MP0006054_spinal_hemorrhage | 1.34222911 |
| 29 | MP0009278_abnormal_bone_marrow | 1.33303099 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.30334941 |
| 31 | MP0000733_abnormal_muscle_development | 1.26283176 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.25505419 |
| 33 | MP0000750_abnormal_muscle_regeneration | 1.22920020 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.20404755 |
| 35 | MP0004957_abnormal_blastocyst_morpholog | 1.19932853 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.19647943 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.19476696 |
| 38 | MP0003693_abnormal_embryo_hatching | 1.19185200 |
| 39 | MP0005275_abnormal_skin_tensile | 1.18835895 |
| 40 | MP0000751_myopathy | 1.18641093 |
| 41 | MP0001348_abnormal_lacrimal_gland | 1.17301838 |
| 42 | MP0001849_ear_inflammation | 1.16921336 |
| 43 | MP0001835_abnormal_antigen_presentation | 1.16876708 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.16029842 |
| 45 | MP0003828_pulmonary_edema | 1.15751926 |
| 46 | MP0005409_darkened_coat_color | 1.14490959 |
| 47 | MP0001730_embryonic_growth_arrest | 1.12787288 |
| 48 | MP0003436_decreased_susceptibility_to | 1.12153889 |
| 49 | MP0010307_abnormal_tumor_latency | 1.11243104 |
| 50 | MP0005332_abnormal_amino_acid | 1.10542641 |
| 51 | MP0002419_abnormal_innate_immunity | 1.08146901 |
| 52 | MP0000490_abnormal_crypts_of | 1.07800953 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.07598551 |
| 54 | MP0000678_abnormal_parathyroid_gland | 1.07200132 |
| 55 | MP0002877_abnormal_melanocyte_morpholog | 1.06705356 |
| 56 | MP0005025_abnormal_response_to | 1.05923969 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.05547743 |
| 58 | MP0005387_immune_system_phenotype | 1.03547895 |
| 59 | MP0001790_abnormal_immune_system | 1.03547895 |
| 60 | MP0000598_abnormal_liver_morphology | 1.03495570 |
| 61 | MP0004197_abnormal_fetal_growth/weight/ | 1.02051883 |
| 62 | MP0004947_skin_inflammation | 1.01670360 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 1.01474255 |
| 64 | MP0009643_abnormal_urine_homeostasis | 0.99983707 |
| 65 | MP0001666_abnormal_nutrient_absorption | 0.99877125 |
| 66 | MP0000759_abnormal_skeletal_muscle | 0.98363104 |
| 67 | MP0003111_abnormal_nucleus_morphology | 0.97662607 |
| 68 | MP0002088_abnormal_embryonic_growth/wei | 0.96763423 |
| 69 | MP0010630_abnormal_cardiac_muscle | 0.96002809 |
| 70 | MP0003984_embryonic_growth_retardation | 0.95768752 |
| 71 | MP0005621_abnormal_cell_physiology | 0.95515336 |
| 72 | MP0000685_abnormal_immune_system | 0.94860505 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 0.93771712 |
| 74 | MP0002089_abnormal_postnatal_growth/wei | 0.93340954 |
| 75 | MP0000343_altered_response_to | 0.93320091 |
| 76 | MP0010030_abnormal_orbit_morphology | 0.92977993 |
| 77 | MP0002086_abnormal_extraembryonic_tissu | 0.92856135 |
| 78 | MP0010368_abnormal_lymphatic_system | 0.91802006 |
| 79 | MP0003077_abnormal_cell_cycle | 0.91362344 |
| 80 | MP0001672_abnormal_embryogenesis/_devel | 0.91252937 |
| 81 | MP0005380_embryogenesis_phenotype | 0.91252937 |
| 82 | MP0003172_abnormal_lysosome_physiology | 0.91012933 |
| 83 | MP0001915_intracranial_hemorrhage | 0.90817419 |
| 84 | MP0000003_abnormal_adipose_tissue | 0.90553512 |
| 85 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90386125 |
| 86 | MP0003279_aneurysm | 0.90379070 |
| 87 | MP0004087_abnormal_muscle_fiber | 0.90332612 |
| 88 | MP0002060_abnormal_skin_morphology | 0.90242384 |
| 89 | MP0002452_abnormal_antigen_presenting | 0.89771022 |
| 90 | MP0005390_skeleton_phenotype | 0.89122931 |
| 91 | MP0002398_abnormal_bone_marrow | 0.88832440 |
| 92 | MP0004084_abnormal_cardiac_muscle | 0.87802533 |
| 93 | MP0005257_abnormal_intraocular_pressure | 0.86988833 |
| 94 | MP0004019_abnormal_vitamin_homeostasis | 0.86977969 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.86323418 |
| 96 | MP0002420_abnormal_adaptive_immunity | 0.86138468 |
| 97 | MP0000747_muscle_weakness | 0.85932150 |
| 98 | MP0001819_abnormal_immune_cell | 0.85806686 |
| 99 | MP0002723_abnormal_immune_serum | 0.85066579 |
| 100 | MP0005503_abnormal_tendon_morphology | 0.84891015 |
| 101 | MP0001216_abnormal_epidermal_layer | 0.83493283 |
| 102 | MP0001243_abnormal_dermal_layer | 0.83403409 |
| 103 | MP0005375_adipose_tissue_phenotype | 0.82985319 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.82735858 |
| 105 | MP0005670_abnormal_white_adipose | 0.82610837 |
| 106 | MP0009785_altered_susceptibility_to | 0.82471106 |
| 107 | MP0003075_altered_response_to | 0.82429875 |
| 108 | MP0000350_abnormal_cell_proliferation | 0.82199863 |
| 109 | MP0002148_abnormal_hypersensitivity_rea | 0.82159174 |
| 110 | MP0002269_muscular_atrophy | 0.81394926 |
| 111 | MP0002796_impaired_skin_barrier | 0.81075445 |
| 112 | MP0001873_stomach_inflammation | 0.80949943 |
| 113 | MP0004130_abnormal_muscle_cell | 0.80904395 |
| 114 | MP0005330_cardiomyopathy | 0.79979345 |
| 115 | MP0000858_altered_metastatic_potential | 0.79774100 |
| 116 | MP0001697_abnormal_embryo_size | 0.79642923 |
| 117 | MP0000703_abnormal_thymus_morphology | 0.79465254 |
| 118 | MP0002166_altered_tumor_susceptibility | 0.78660002 |
| 119 | MP0002405_respiratory_system_inflammati | 0.77964807 |
| 120 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77449678 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 0.77378874 |
| 122 | MP0002429_abnormal_blood_cell | 0.77241449 |
| 123 | MP0002080_prenatal_lethality | 0.76994430 |
| 124 | MP0001542_abnormal_bone_strength | 0.76293782 |
| 125 | MP0009672_abnormal_birth_weight | 0.75139970 |
| 126 | MP0000716_abnormal_immune_system | 0.74111688 |
| 127 | MP0002118_abnormal_lipid_homeostasis | 0.73843395 |
| 128 | MP0004808_abnormal_hematopoietic_stem | 0.73750769 |
| 129 | MP0004272_abnormal_basement_membrane | 0.73646728 |
| 130 | MP0002722_abnormal_immune_system | 0.73518048 |
| 131 | MP0003091_abnormal_cell_migration | 0.73081596 |
| 132 | MP0005501_abnormal_skin_physiology | 0.71278486 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.70110262 |
| 134 | MP0001800_abnormal_humoral_immune | 0.70023062 |
| 135 | MP0003186_abnormal_redox_activity | 0.69850293 |
| 136 | MP0000767_abnormal_smooth_muscle | 0.69689639 |
| 137 | MP0005397_hematopoietic_system_phenotyp | 0.69460426 |
| 138 | MP0001545_abnormal_hematopoietic_system | 0.69460426 |
| 139 | MP0005451_abnormal_body_composition | 0.69196300 |
| 140 | MP0003448_altered_tumor_morphology | 0.69129445 |
| 141 | MP0002019_abnormal_tumor_incidence | 0.68255934 |
| 142 | MP0001958_emphysema | 0.67525789 |
| 143 | MP0002092_abnormal_eye_morphology | 0.67254563 |
| 144 | MP0010155_abnormal_intestine_physiology | 0.66844401 |
| 145 | MP0002396_abnormal_hematopoietic_system | 0.65509323 |
| 146 | MP0002085_abnormal_embryonic_tissue | 0.65282765 |
| 147 | MP0001853_heart_inflammation | 0.64978637 |
| 148 | MP0000377_abnormal_hair_follicle | 0.64897039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 3.86076104 |
| 2 | Vertebral compression fractures (HP:0002953) | 3.37257940 |
| 3 | Xanthomatosis (HP:0000991) | 3.32173676 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.17423462 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.14651939 |
| 6 | Increased connective tissue (HP:0009025) | 2.93471033 |
| 7 | Multiple enchondromatosis (HP:0005701) | 2.85456583 |
| 8 | Premature rupture of membranes (HP:0001788) | 2.76897450 |
| 9 | Distal lower limb amyotrophy (HP:0008944) | 2.75852526 |
| 10 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.70516070 |
| 11 | Cerebral aneurysm (HP:0004944) | 2.70412730 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 2.64812241 |
| 13 | Spinal rigidity (HP:0003306) | 2.61807977 |
| 14 | Increased variability in muscle fiber diameter (HP:0003557) | 2.57386969 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 2.55976082 |
| 16 | Distal lower limb muscle weakness (HP:0009053) | 2.54485619 |
| 17 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.54363066 |
| 18 | Complement deficiency (HP:0004431) | 2.53032142 |
| 19 | Myocardial infarction (HP:0001658) | 2.52495413 |
| 20 | Spastic diplegia (HP:0001264) | 2.52394468 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.49357092 |
| 22 | Peritonitis (HP:0002586) | 2.46923810 |
| 23 | Ulnar bowing (HP:0003031) | 2.36465607 |
| 24 | Hypoglycemic coma (HP:0001325) | 2.36265334 |
| 25 | Hyperammonemia (HP:0001987) | 2.36035840 |
| 26 | Abnormality of complement system (HP:0005339) | 2.34651413 |
| 27 | Disproportionate tall stature (HP:0001519) | 2.34401298 |
| 28 | Abnormal cartilage morphology (HP:0002763) | 2.34024234 |
| 29 | Esophageal varix (HP:0002040) | 2.31192498 |
| 30 | Fragile skin (HP:0001030) | 2.29620035 |
| 31 | Abnormality of the Achilles tendon (HP:0005109) | 2.27030489 |
| 32 | Rhabdomyolysis (HP:0003201) | 2.25195613 |
| 33 | Cervical subluxation (HP:0003308) | 2.24922173 |
| 34 | Hyperglycinuria (HP:0003108) | 2.23651267 |
| 35 | Hypolipoproteinemia (HP:0010981) | 2.23247020 |
| 36 | Myoglobinuria (HP:0002913) | 2.20916756 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.17246152 |
| 38 | Difficulty climbing stairs (HP:0003551) | 2.13818935 |
| 39 | Cellulitis (HP:0100658) | 2.12490776 |
| 40 | Shallow orbits (HP:0000586) | 2.12291600 |
| 41 | Exercise-induced muscle cramps (HP:0003710) | 2.11044257 |
| 42 | Bladder diverticulum (HP:0000015) | 2.10695388 |
| 43 | Broad face (HP:0000283) | 2.10397025 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.08999112 |
| 45 | Mitral valve prolapse (HP:0001634) | 2.08268518 |
| 46 | Back pain (HP:0003418) | 2.05974004 |
| 47 | Syringomyelia (HP:0003396) | 2.05842268 |
| 48 | Spinal cord lesions (HP:0100561) | 2.05842268 |
| 49 | Achilles tendon contracture (HP:0001771) | 2.05134187 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.05094602 |
| 51 | Lymphangioma (HP:0100764) | 2.04293843 |
| 52 | Wormian bones (HP:0002645) | 2.04222398 |
| 53 | Polycythemia (HP:0001901) | 2.03492469 |
| 54 | Ketosis (HP:0001946) | 2.03379799 |
| 55 | Increased density of long bones (HP:0006392) | 2.02841980 |
| 56 | Right ventricular cardiomyopathy (HP:0011663) | 2.02749587 |
| 57 | Flat acetabular roof (HP:0003180) | 2.01874742 |
| 58 | Mitral regurgitation (HP:0001653) | 2.01508794 |
| 59 | Vascular tortuosity (HP:0004948) | 2.01397682 |
| 60 | Abnormality of the common coagulation pathway (HP:0010990) | 2.01122769 |
| 61 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00859514 |
| 62 | Ankle contracture (HP:0006466) | 2.00579230 |
| 63 | Long palpebral fissure (HP:0000637) | 2.00527896 |
| 64 | Rectal prolapse (HP:0002035) | 2.00446277 |
| 65 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.99564002 |
| 66 | Abnormality of glycine metabolism (HP:0010895) | 1.99564002 |
| 67 | Systemic lupus erythematosus (HP:0002725) | 1.99063595 |
| 68 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.98011838 |
| 69 | Atrophic scars (HP:0001075) | 1.98001637 |
| 70 | Hyperlipoproteinemia (HP:0010980) | 1.97994653 |
| 71 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.96304444 |
| 72 | Asymmetry of the thorax (HP:0001555) | 1.96086675 |
| 73 | Late onset (HP:0003584) | 1.95765815 |
| 74 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.95416476 |
| 75 | Arterial tortuosity (HP:0005116) | 1.94351213 |
| 76 | Short nail (HP:0001799) | 1.94291984 |
| 77 | Muscle fiber splitting (HP:0003555) | 1.91384469 |
| 78 | Type 1 muscle fiber predominance (HP:0003803) | 1.90714862 |
| 79 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89833508 |
| 80 | Osteolytic defects of the hand bones (HP:0009699) | 1.89833508 |
| 81 | Biconcave vertebral bodies (HP:0004586) | 1.89029567 |
| 82 | Elbow flexion contracture (HP:0002987) | 1.88744600 |
| 83 | Aneurysm (HP:0002617) | 1.86917264 |
| 84 | Hepatocellular carcinoma (HP:0001402) | 1.86677438 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 1.86288439 |
| 86 | Generalized amyotrophy (HP:0003700) | 1.86269436 |
| 87 | Spondylolisthesis (HP:0003302) | 1.86138584 |
| 88 | Hyperparathyroidism (HP:0000843) | 1.84176046 |
| 89 | Emphysema (HP:0002097) | 1.83717989 |
| 90 | Metaphyseal cupping (HP:0003021) | 1.82386985 |
| 91 | Distal upper limb amyotrophy (HP:0007149) | 1.82204282 |
| 92 | Upper limb amyotrophy (HP:0009129) | 1.82204282 |
| 93 | Gout (HP:0001997) | 1.81823512 |
| 94 | Insomnia (HP:0100785) | 1.81591393 |
| 95 | Lower limb amyotrophy (HP:0007210) | 1.81214396 |
| 96 | Interstitial pulmonary disease (HP:0006530) | 1.80282402 |
| 97 | Ventricular tachycardia (HP:0004756) | 1.80133024 |
| 98 | Myopathic facies (HP:0002058) | 1.79500336 |
| 99 | Abnormality of macrophages (HP:0004311) | 1.79370294 |
| 100 | Fatigue (HP:0012378) | 1.78770985 |
| 101 | Hyporeflexia of lower limbs (HP:0002600) | 1.78654946 |
| 102 | Ulnar deviation of the wrist (HP:0003049) | 1.77699010 |
| 103 | Slender build (HP:0001533) | 1.77361536 |
| 104 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.76047192 |
| 105 | Abnormality of oral frenula (HP:0000190) | 1.74523420 |
| 106 | Persistence of primary teeth (HP:0006335) | 1.74272764 |
| 107 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73357731 |
| 108 | Gastrointestinal stroma tumor (HP:0100723) | 1.73290751 |
| 109 | Dysostosis multiplex (HP:0000943) | 1.73183110 |
| 110 | Trismus (HP:0000211) | 1.73112791 |
| 111 | Abnormality of the thoracic spine (HP:0100711) | 1.72882443 |
| 112 | Blue sclerae (HP:0000592) | 1.72539767 |
| 113 | Natal tooth (HP:0000695) | 1.72035141 |
| 114 | Hyperglycinemia (HP:0002154) | 1.71765929 |
| 115 | Mesangial abnormality (HP:0001966) | 1.71154714 |
| 116 | Abnormality of glycolipid metabolism (HP:0010969) | 1.70217714 |
| 117 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.70217714 |
| 118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.70217714 |
| 119 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.69835767 |
| 120 | Genu recurvatum (HP:0002816) | 1.69738504 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 1.69203720 |
| 122 | Pseudobulbar signs (HP:0002200) | 1.69107782 |
| 123 | Difficulty running (HP:0009046) | 1.68992481 |
| 124 | Increased serum ferritin (HP:0003281) | 1.67432605 |
| 125 | Obstructive sleep apnea (HP:0002870) | 1.67424146 |
| 126 | Hematochezia (HP:0002573) | 1.66748888 |
| 127 | Abnormality of nucleobase metabolism (HP:0010932) | 1.66310384 |
| 128 | Joint laxity (HP:0001388) | 1.66219960 |
| 129 | Papilloma (HP:0012740) | 1.66176145 |
| 130 | Verrucae (HP:0200043) | 1.66176145 |
| 131 | Epidermoid cyst (HP:0200040) | 1.65749191 |
| 132 | Ketoacidosis (HP:0001993) | 1.65681275 |
| 133 | Increased IgE level (HP:0003212) | 1.65052484 |
| 134 | Progressive muscle weakness (HP:0003323) | 1.64732021 |
| 135 | Hemorrhage of the eye (HP:0011885) | 1.64625526 |
| 136 | Ankyloglossia (HP:0010296) | 1.64612821 |
| 137 | Angiofibromas (HP:0010615) | 1.64575043 |
| 138 | Adenoma sebaceum (HP:0009720) | 1.64575043 |
| 139 | Hypertensive crisis (HP:0100735) | 1.64250030 |
| 140 | Dilatation of the ascending aorta (HP:0005111) | 1.63862358 |
| 141 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.63471609 |
| 142 | Subacute progressive viral hepatitis (HP:0006572) | 1.63067604 |
| 143 | Axonal loss (HP:0003447) | 1.63025448 |
| 144 | Cupped ribs (HP:0000887) | 1.63010345 |
| 145 | Malnutrition (HP:0004395) | 1.62045000 |
| 146 | Round ear (HP:0100830) | 1.61582457 |
| 147 | Abnormality of purine metabolism (HP:0004352) | 1.61441979 |
| 148 | Abnormality of the acetabulum (HP:0003170) | 1.61262291 |
| 149 | Exercise-induced myalgia (HP:0003738) | 1.60468572 |
| 150 | Hyperacusis (HP:0010780) | 1.60400802 |
| 151 | Abnormality of the peritoneum (HP:0002585) | 1.59955850 |
| 152 | Skin nodule (HP:0200036) | 1.58896786 |
| 153 | Increased mean platelet volume (HP:0011877) | 1.58275788 |
| 154 | Thin bony cortex (HP:0002753) | 1.57869437 |
| 155 | Abnormality of the nasal mucosa (HP:0000433) | 1.57650558 |
| 156 | Aortic dissection (HP:0002647) | 1.55903957 |
| 157 | Chondrocalcinosis (HP:0000934) | 1.55671598 |
| 158 | Abnormal ossification of hand bones (HP:0005921) | 1.55614356 |
| 159 | Thoracic kyphosis (HP:0002942) | 1.55420347 |
| 160 | Joint hemorrhage (HP:0005261) | 1.55145304 |
| 161 | Polygenic inheritance (HP:0010982) | 1.54325169 |
| 162 | Hypercholesterolemia (HP:0003124) | 1.54255286 |
| 163 | Aortic aneurysm (HP:0004942) | 1.53893532 |
| 164 | Hyperextensible skin (HP:0000974) | 1.53755742 |
| 165 | Bowed forearm bones (HP:0003956) | 1.53669605 |
| 166 | Bowing of the arm (HP:0006488) | 1.53669605 |
| 167 | Patellar dislocation (HP:0002999) | 1.53047234 |
| 168 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.51702123 |
| 169 | Abnormality of the calcaneus (HP:0008364) | 1.51466550 |
| 170 | Bone pain (HP:0002653) | 1.51366073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.54851740 |
| 2 | PKN2 | 3.83834901 |
| 3 | PRPF4B | 3.74688569 |
| 4 | MAP3K10 | 3.25177908 |
| 5 | ERN1 | 2.99133861 |
| 6 | SMG1 | 2.98386411 |
| 7 | EEF2K | 2.91450078 |
| 8 | IRAK3 | 2.78137327 |
| 9 | TTN | 2.51133808 |
| 10 | SIK1 | 2.05757698 |
| 11 | LRRK2 | 1.94418134 |
| 12 | BCKDK | 1.93002977 |
| 13 | MAP4K1 | 1.91712613 |
| 14 | FGFR4 | 1.91042756 |
| 15 | PTK6 | 1.82926063 |
| 16 | TAOK2 | 1.81545056 |
| 17 | CDK12 | 1.75066624 |
| 18 | STK10 | 1.69537460 |
| 19 | EPHA2 | 1.48467193 |
| 20 | PAK4 | 1.46307391 |
| 21 | MAP3K13 | 1.43782631 |
| 22 | RPS6KA4 | 1.38380441 |
| 23 | MAP3K14 | 1.35357097 |
| 24 | NEK2 | 1.34570935 |
| 25 | TESK2 | 1.31372259 |
| 26 | BMX | 1.31205008 |
| 27 | LATS1 | 1.30220527 |
| 28 | RPS6KB2 | 1.29444194 |
| 29 | NME2 | 1.27207555 |
| 30 | KDR | 1.26941255 |
| 31 | MAP2K3 | 1.26097273 |
| 32 | FLT3 | 1.24066647 |
| 33 | ARAF | 1.23433194 |
| 34 | TYK2 | 1.23267925 |
| 35 | KSR2 | 1.22795903 |
| 36 | EPHB1 | 1.22599241 |
| 37 | RIPK1 | 1.22413427 |
| 38 | PDGFRA | 1.21504802 |
| 39 | GRK6 | 1.20043388 |
| 40 | NEK1 | 1.19579994 |
| 41 | MST1R | 1.17708967 |
| 42 | MAP3K8 | 1.14453202 |
| 43 | CDK4 | 1.12323995 |
| 44 | TGFBR2 | 1.11913113 |
| 45 | CDC42BPA | 1.09411864 |
| 46 | MOS | 1.07428507 |
| 47 | MAP3K11 | 1.06788398 |
| 48 | MTOR | 1.06136547 |
| 49 | MAP3K3 | 1.05147415 |
| 50 | CDK6 | 1.03454845 |
| 51 | RIPK4 | 1.00278504 |
| 52 | ICK | 0.99197134 |
| 53 | TBK1 | 0.96000515 |
| 54 | MAP3K1 | 0.93529883 |
| 55 | IRAK4 | 0.92315967 |
| 56 | PRKD2 | 0.91874643 |
| 57 | NEK9 | 0.91238035 |
| 58 | MET | 0.90959259 |
| 59 | ZAP70 | 0.90060336 |
| 60 | SIK3 | 0.86972797 |
| 61 | ALK | 0.84815068 |
| 62 | BUB1 | 0.84611515 |
| 63 | DYRK1B | 0.84581223 |
| 64 | ILK | 0.83872684 |
| 65 | STK4 | 0.83608450 |
| 66 | PIM1 | 0.83428135 |
| 67 | TGFBR1 | 0.80159975 |
| 68 | PAK2 | 0.79473374 |
| 69 | SCYL2 | 0.79231658 |
| 70 | BLK | 0.78562504 |
| 71 | STK3 | 0.78475072 |
| 72 | PASK | 0.74343993 |
| 73 | CSK | 0.72182587 |
| 74 | CSF1R | 0.71732723 |
| 75 | MAPKAPK3 | 0.69814387 |
| 76 | JAK3 | 0.67959267 |
| 77 | PDPK1 | 0.66612401 |
| 78 | RPS6KA2 | 0.66479558 |
| 79 | WEE1 | 0.65869358 |
| 80 | LIMK1 | 0.64998550 |
| 81 | FGFR3 | 0.64805311 |
| 82 | TTK | 0.63327518 |
| 83 | CHUK | 0.63180541 |
| 84 | MAPK11 | 0.63115865 |
| 85 | TESK1 | 0.62698919 |
| 86 | DDR2 | 0.60897476 |
| 87 | CDK7 | 0.60535783 |
| 88 | HIPK2 | 0.60304607 |
| 89 | TLK1 | 0.59665362 |
| 90 | PTK2 | 0.59573284 |
| 91 | BRAF | 0.59277669 |
| 92 | MARK2 | 0.58983230 |
| 93 | IRAK2 | 0.58801161 |
| 94 | MAP2K2 | 0.58667079 |
| 95 | MARK3 | 0.58008965 |
| 96 | EPHA3 | 0.57957008 |
| 97 | MAP3K6 | 0.57795657 |
| 98 | DYRK3 | 0.56540807 |
| 99 | PIM2 | 0.56100076 |
| 100 | CLK1 | 0.55959141 |
| 101 | LMTK2 | 0.55255683 |
| 102 | AURKB | 0.54126173 |
| 103 | EPHB2 | 0.53982888 |
| 104 | JAK1 | 0.52672761 |
| 105 | BTK | 0.51111517 |
| 106 | NTRK1 | 0.49739342 |
| 107 | MYLK | 0.48810766 |
| 108 | MAP3K7 | 0.48567417 |
| 109 | JAK2 | 0.48244904 |
| 110 | FGFR1 | 0.48071654 |
| 111 | RPS6KA1 | 0.46846778 |
| 112 | ITK | 0.46754843 |
| 113 | GSK3A | 0.46281032 |
| 114 | AKT2 | 0.45511854 |
| 115 | RET | 0.43297327 |
| 116 | PAK1 | 0.42958812 |
| 117 | DMPK | 0.42242454 |
| 118 | PRKG2 | 0.42133738 |
| 119 | CDK9 | 0.41944432 |
| 120 | IKBKB | 0.41085077 |
| 121 | CAMK1D | 0.38327227 |
| 122 | RAF1 | 0.36554117 |
| 123 | LATS2 | 0.35410484 |
| 124 | PRKD3 | 0.35213426 |
| 125 | TAOK1 | 0.35001492 |
| 126 | CDK8 | 0.34689694 |
| 127 | MAPKAPK2 | 0.34456938 |
| 128 | PDGFRB | 0.34414183 |
| 129 | MAPK7 | 0.34371638 |
| 130 | HCK | 0.34183104 |
| 131 | CDC7 | 0.33387739 |
| 132 | PIK3CG | 0.33118686 |
| 133 | RPS6KC1 | 0.33008516 |
| 134 | RPS6KL1 | 0.33008516 |
| 135 | RPS6KA6 | 0.32374169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.90225211 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.46045022 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.25828095 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.25696744 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.23384756 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.19515993 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.09999997 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.09618676 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.01682614 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.97845423 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.81688278 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.77945314 |
| 13 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.76834815 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.76720495 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.76204104 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.66366398 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.64719269 |
| 18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.62580441 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.56149028 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55924430 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49567932 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.49470151 |
| 23 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.47996546 |
| 24 | Prion diseases_Homo sapiens_hsa05020 | 1.47362710 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.47353509 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.46434258 |
| 27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.46042869 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45524067 |
| 29 | Thyroid cancer_Homo sapiens_hsa05216 | 1.45382942 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41194002 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39507868 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.36289782 |
| 33 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.33367516 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30830821 |
| 35 | Lysine degradation_Homo sapiens_hsa00310 | 1.30225973 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29308909 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.27608824 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.27560784 |
| 39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.24713368 |
| 40 | Ribosome_Homo sapiens_hsa03010 | 1.24531616 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.22846001 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.22197311 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.20938043 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20653960 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20111846 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18352627 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.16134917 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.12860017 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09142868 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.04744984 |
| 51 | Prostate cancer_Homo sapiens_hsa05215 | 1.04573063 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04140479 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.02708921 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02376431 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99953441 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99929155 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99282914 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99134465 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.96793598 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95731430 |
| 61 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.95721043 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.95660555 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94906438 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93654774 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93244466 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93142633 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.92601872 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92333122 |
| 69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91178086 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.90702112 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89196598 |
| 72 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87910588 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.87032056 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86255609 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85789565 |
| 76 | Tuberculosis_Homo sapiens_hsa05152 | 0.85244843 |
| 77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84791769 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83813711 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.83475618 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.83434103 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83367457 |
| 82 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82255039 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82010039 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80348684 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.80340785 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79261120 |
| 87 | DNA replication_Homo sapiens_hsa03030 | 0.78924881 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77970066 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.77698789 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77570307 |
| 91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.77125741 |
| 92 | RNA transport_Homo sapiens_hsa03013 | 0.76232685 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75873128 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75261464 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75176873 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.74775503 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73807558 |
| 98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73000688 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72038919 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71302085 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71169462 |
| 102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71016213 |
| 103 | Bile secretion_Homo sapiens_hsa04976 | 0.70482867 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70480458 |
| 105 | Histidine metabolism_Homo sapiens_hsa00340 | 0.70196480 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67964786 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67817903 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67565409 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.67362575 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67356549 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67142639 |
| 112 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.66639758 |
| 113 | Spliceosome_Homo sapiens_hsa03040 | 0.66597797 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66125008 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65029818 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63981860 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63673568 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.62927010 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61583355 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61478147 |
| 121 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61425644 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60869733 |
| 123 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60559372 |
| 124 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60414658 |
| 125 | Platelet activation_Homo sapiens_hsa04611 | 0.59764528 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.59429429 |
| 127 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59233062 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59228315 |
| 129 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58506656 |
| 130 | Focal adhesion_Homo sapiens_hsa04510 | 0.58167138 |
| 131 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57323119 |
| 132 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56586490 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56503033 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56037466 |
| 135 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55974553 |
| 136 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.55723527 |
| 137 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55456502 |
| 138 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.54289605 |
| 139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54127911 |
| 140 | Leishmaniasis_Homo sapiens_hsa05140 | 0.53865251 |
| 141 | Phagosome_Homo sapiens_hsa04145 | 0.52077063 |
| 142 | Base excision repair_Homo sapiens_hsa03410 | 0.52041604 |
| 143 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51850060 |
| 144 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50903434 |
| 145 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50085434 |
| 146 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50044668 |
| 147 | Amoebiasis_Homo sapiens_hsa05146 | 0.48035587 |
| 148 | Allograft rejection_Homo sapiens_hsa05330 | 0.46735982 |
| 149 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46430003 |
| 150 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.46064989 |
| 151 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45093880 |
| 152 | Mismatch repair_Homo sapiens_hsa03430 | 0.43475168 |
| 153 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.42807016 |
| 154 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40820824 |
| 155 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.40579182 |
| 156 | Cell cycle_Homo sapiens_hsa04110 | 0.39578941 |
| 157 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39497097 |
| 158 | ABC transporters_Homo sapiens_hsa02010 | 0.38168243 |

